Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies
- 344 Downloads
Current treatments for seizure emergencies, such as status epilepticus, include intravenous or rectal administration of benzodiazepines. While intranasal delivery of these drugs is desirable, the small volume of the nasal cavity and low drug solubility pose significant difficulties. Here, we prepared supersaturated diazepam solutions under physiological conditions and without precipitation, using a prodrug/enzyme system. Avizafone, a peptide prodrug of diazepam, was delivered with—Aspergillus oryzae (A.O.) protease, an enzyme identified from a pool of hydrolytic enzymes in assay buffer, pH 7.4 at 32°C. This enzyme converted avizafone to diazepam at supersaturated concentrations. In vitro permeability studies were performed at various prodrug/enzyme ratios using Madin-Darby canine kidney II-wild type (MDCKII-wt) monolayers, a representative model of the nasal epithelium. Monolayer integrity was examined using TEER measurement and the lucifer yellow permeability assay. Prodrug/drug concentrations were measured using HPLC. Enzyme kinetics with avizafone-protease mixtures revealed K M = 1,501 ± 232 μM and V max = 1,369 ± 94 μM/s. Prodrug-protease mixtures, when co-delivered apically onto MDCKII-wt monolayers, showed 2–17.6-fold greater diazepam flux (S = 1.3–15.3) compared to near-saturated diazepam (S = 0.7). Data for prodrug conversion upstream (apical side) and drug permeability downstream (basolateral side) fitted reasonably well to a previously developed in vitro two compartment pharmacokinetic model. Avizafone-protease mixtures resulted in supersaturated diazepam in less than 5 min, with the rate and extent of supersaturation determined by the prodrug/enzyme ratio. Together, these results suggest that an intranasal avizafone-protease system may provide a rapid and alternative means of diazepam delivery.
KEY WORDSavizafone enzyme activation diazepam delivery hydrophobic drugs MDCK monolayers rapid absorption seizure emergencies supersaturation
We thank the AHC Faculty Research Development Program at the University of Minnesota for research funding (grant#1803-11406-21287-3672675, PI G. Georg). We thank Dr. Subhashree Francis for providing data for Supplemental 1 (LC-MS). We also thank Prof. William Elmquist for providing lab facilities to perform cell studies, and Prof. Karunya Kandimalla for providing the HPLC equipment. Discussions with Profs. James Cloyd, Edward Patterson and Patrick E. Hanna are gratefully acknowledged.
- 3.Abou-Khalil B, Wheless J, Rogin J, Wolter KD, Pixton GC, Shukla RB, et al. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia. 2013;54(11):1968–76.PubMedCrossRefGoogle Scholar
- 8.Ibach H. Nucleation and growth. Physics of surfaces and interfaces. Berlin: Springer; 2006.Google Scholar
- 9.Hsieh Y-L, Ilevbare G, Van Eerdenbrugh B, Box K, Sanchez-Felix M, Taylor L. pH-induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties. Pharm Res. 2012;29(10):2738–53.PubMedCrossRefGoogle Scholar
- 19.Karlsson B, Lindgren B, Waterhouse E, Sandberg M, Sellström A. On the use of diazepam and pro-diazepam (2-benzoyl-4-chloro-N-methyl-N-lysylglycin anilide), as adjunct antidotes in the treatment of organophosphorus intoxication in the guinea-pig. J Pharm Pharmacol. 1990;42(4):247–51.PubMedCrossRefGoogle Scholar
- 20.Lallement G, Renault F, Baubichon D, Peoc’h M, Burckhart MF, Galonnier M, et al. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazepine pharmacokinetics. Arch Toxicol. 2000;74(8):480–6.PubMedCrossRefGoogle Scholar
- 21.Hassall CH, Johnson WH, Krohn A, Smithen CE, Thomas WA, inventors; Phenyl keto derivatives of lysyl glycinamide. AU514778B2, Australia. 1981.Google Scholar
- 22.Hassall CH, Johnson WH, Krohn A, Smithen CE, Thomas WA, inventors; A substituted-phenyl ketone containing a dipeptide residue and a process for the manufacture thereof. GB1517166A, UK. 1974 20 Aug 1974.Google Scholar
- 23.FDA guidelines, Guidance for industry. Q2B Validation of Analytical Procedures: Methodology. November 1996.Google Scholar
- 25.Auret BJ, Boyd DR, Breen F, Greene RME, Robinson PM. Stereoselective enzyme-catalysed oxidation-reduction reactions of thioacetals-thioacetal sulphoxides by fungi. J Chem Soc, Perkin Transactions 1. 1981(0):930–3.Google Scholar
- 27.Wildberger P, Brecker L, Nidetzky B. Chiral resolution through stereoselective transglycosylation by sucrose phosphorylase: application to the synthesis of a new biomimetic compatible solute, (R)-2-O-[small alpha]-d-glucopyranosyl glyceric acid amide. Chem Commun. 2013;50(4):436–8.CrossRefGoogle Scholar